Why a Complete GLP‑1 Drug List Matters for Your Tracking Routine

Many people juggle fragmented notes, screenshots, and scattered reminders when managing GLP‑1 routines. A single, comprehensive GLP‑1 drug list reduces tracking errors and stops routine fragmentation (Affordable access to GLP‑1 obesity medications – NIH PMC). Clear lists also support better adherence. Real‑world studies report adherence above 85% for GLP‑1 therapies (Real‑world persistence and adherence to glucagon‑like peptide‑1 therapies – JMCP 2024). A May 2024 poll found 62% of adults who took a GLP‑1 drug used it for chronic conditions like diabetes or heart disease (KFF Health Tracking Poll May 2024). A complete list speeds setup, so reminders match your prescribed schedule. It also improves the quality of notes you bring to clinic visits. Pepio helps you keep a single, accurate list so you avoid scattered records and guesswork. This guide gives a numbered checklist and tracking prompts you can drop into your routine. Pepio is for organization and self‑tracking only; follow instructions from your clinician, prescriber, or pharmacist. Learn more about Pepio's approach to routine organization and practical tracking tools.

Top GLP‑1 Drugs and How to Track Them Efficiently

Pepio is listed first below as the recommended all‑in‑one tracker. Each numbered entry includes the drug name and generic, a typical dosing cadence for context, the key fields you should log, and a short “why it matters” note. Dosing examples come from clinical summaries and guidance sources such as StatPearls and specialist overviews to give context, not to replace clinician instructions (see StatPearls and Endocrinology Advisor). Track for organization, clearer clinician conversations, and fewer missed doses. Always follow your prescriber, pharmacist, medication label, or care team for dosing and clinical questions.

1. Track injection date, dose, site, symptoms, food noise, and weight.
2. Built‑in reminders keep you from missing shot days.
3. Exportable reports simplify doctor‑visit prep.
4. Why it matters: consolidates scattered notes into one secure place.

Pepio is the first choice here because it focuses on routine management for injection‑based therapies. Pepio helps you keep your entire injection history, symptom timeline, and weight progress together. Use the app to keep organized records you can share with clinicians, while following their dosing instructions.

• Typical dose: 0.25 mg → 0.5 mg → 1 mg (weekly titration example from clinical summaries, for context) (StatPearls).
• Track weekly dose changes, injection site rotation, and nausea patterns.
• Why it matters: dose escalations are common; tracking helps spot side‑effect trends and links timing to symptoms.

Keep each weekly injection timestamped and note any dose increases. Record nausea onset and duration after each shot to see patterns across titration steps. Always follow your clinician’s instructions about dose changes.

• Dose range: 0.25 mg up to 2.4 mg weekly (context for weight‑loss regimens) (For Hers; StatPearls).
• Log weight, BMI, appetite changes, and weekly symptom scores.
• Why it matters: higher doses often bring stronger appetite suppression; monitoring progress clarifies effectiveness and side effects.

For Wegovy, record baseline weight and weekly weight to calculate percentage change. Note appetite or “food noise” shifts near dose increases so you can report trends at follow‑ups.

• Starts at 2.5 mg and titrates to 15 mg (typical range referenced in clinical overviews) (StatPearls; Endocrinology Advisor).
• Capture dose titration dates, GI side‑effects, and food‑noise fluctuations.
• Why it matters: longer titration schedules benefit from precise date stamps to link symptoms with each step.

Log each titration step with clear date stamps. That makes it easier to see which dose preceded a side effect or appetite change.

• Dose: 5 mg → 10 mg → 15 mg is a common progression in clinical summaries (StatPearls; Endocrinology Advisor).
• Track blood‑sugar trends alongside weight loss and injection site.
• Why it matters: dual‑purpose therapy calls for coordinated logs of glucose and weight to see both outcomes together.

If you monitor glucose at home, timestamp readings near shot days and note any symptomatic changes. That helps you and your clinician review glycemic and weight trends in context.

• Dose: 3 mg → 7 mg → 14 mg daily (typical oral titration) (StatPearls; For Hers).
• Log daily intake time, missed doses, and gastrointestinal symptoms.
• Why it matters: oral schedules differ from weekly injectables; separate reminders prevent confusion.

Record the exact time you take Rybelsus and whether you skipped a dose. That keeps daily pills distinct from weekly injections in your timeline.

• Fixed dose examples: 0.75 mg or 1.5 mg weekly (fixed‑dose options in summaries) (StatPearls).
• Record injection site and any injection‑site reactions.
• Why it matters: fewer dose options simplify tracking, but rotating sites still prevents local irritation.

Even with fixed doses, logging injection‑site notes helps identify lumps, redness, or tenderness over time.

• Typical dose: 5 µg → 10 µg before meals (tied to mealtimes) (StatPearls).
• Track timing relative to meals, nausea peaks, and weight trends.
• Why it matters: multiple daily shots increase the chance of missed doses without a robust log.

For Byetta, note meal timing and when nausea occurs after doses. That reveals patterns linked to mealtime injections.

• Fixed 2 mg weekly (extended‑release formulation) (StatPearls).
• Monitor injection‑site lumps and delayed gastrointestinal effects.
• Why it matters: extended‑release dosing can shift when side effects appear; tracking cadence helps find delayed patterns.

Log any delayed GI symptoms and mark injection sites to distinguish immediate from later reactions.

• Dose: 20 µg once daily is a common short‑acting example in clinical summaries (StatPearls).
• Capture daily fasting glucose, appetite changes, and weight.
• Why it matters: short‑acting GLP‑1s need consistent daily logging to detect short‑term trends.

Record fasting glucose and appetite notes alongside the daily shot to see how short‑acting agents affect day‑to‑day patterns.

Pepio helps you move from scattered notes to a single, organized record of doses, symptoms, and progress. Users tracking GLP‑1s and peptides with Pepio report clearer logs for clinician visits and fewer missed reminders in their routines. Learn more about Pepio’s approach to GLP‑1 routine management and see how keeping dose history, symptom notes, and weight progress together can simplify follow‑ups.

References: clinical overviews and dosing context from StatPearls and specialist resources such as Endocrinology Advisor and For Hers.

Key Takeaways and Your Next Simple Step

A complete GLP‑1 drug list plus consistent logging reduces guesswork and missed doses. Pairing a clear drug list with regular logs for dose, site, symptoms, weight, and reminders cuts routine errors.

Real‑world analyses show much better adherence when people use digital tracking tools. One analysis reported adherence above 85% with app support and persistence near 70% at 24 months with integrated symptom tracking (JMCP). Policy and access reviews also emphasize organized self‑tracking as a useful support for adherence and continuity (NIH PMC).

That clarity matters for people like Jordan managing type‑2 diabetes. Pepio helps centralize dose records, injection sites, symptoms, weight changes, and reminders so your notes are clinician‑ready.

Your next simple step is practical and low‑effort. Try adding your current GLP‑1 medication to Pepio. Then set a reminder for your next shot to start a clean, clinician‑ready record. Track the dose you were instructed to take and follow your clinician's instructions.